Overview

Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection

Status:
Completed
Trial end date:
2021-10-30
Target enrollment:
Participant gender:
Summary
The study included 2 arms Colchicine group: Colchicine + standard therapy of COVID-19 Control group: Standard therapy of COVID-19
Phase:
Phase 1
Details
Lead Sponsor:
University of Baghdad
Treatments:
Colchicine